Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.
Press releases published on April 17, 2025
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
GlobeNewswire
·
April 17, 2025
CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, …
Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
GlobeNewswire
·
April 17, 2025
WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report …
GSI Technology to Announce Fiscal Fourth Quarter and Year End 2025 Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true …
Rezolve Ai to Announce Second Half and Full Year 2024 Financial Results on April 24, 2025 and Host a 2025 Business Update Conference Call on April 28, 2025
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, announces that the Company will report second half and full year 2024 financial results on Thursday, April 24, 2025 after market …
authID Joins the Secure Technology Alliance to Advance the Development of Global Identity Standards Across Authentication Technologies
GlobeNewswire
·
April 17, 2025
This membership underscores commitment to enhancing data protection and user privacy through industry collaboration DENVER, COLORADO, April 17, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID), a leading provider of biometric identity verification and …
Beghou Consulting Names Award-Winning Artificial Intelligence Executive, Thought Leader, and Inventor as New VP, AI Innovation
GlobeNewswire
·
April 17, 2025
EVANSTON, Ill., April 17, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions to life sciences companies, today announced that acclaimed artificial intelligence (AI) and machine learning leader …
Tilray Medical Introduces Cannabis Edibles in Australia
GlobeNewswire
·
April 17, 2025
SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners …
CareCloud to Announce First Quarter 2025 Results on May 6, 2025
GlobeNewswire
·
April 17, 2025
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first …
Infinidat Recognized on the CRN® Storage 100 List for the Sixth Consecutive Year; Recognized as One of 2025’s 50 Coolest Software-Defined Storage Vendors
GlobeNewswire
·
April 17, 2025
WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that CRN®, a brand of The Channel Company, has included Infinidat on the 2025 CRN Storage 100 list in the Software Defined …
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
GlobeNewswire
·
April 17, 2025
-- Retrospective analysis reveals no significant differences in comorbidities in narcolepsy patients treated vs. not treated with sodium oxybate -- -- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most …
Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors
GlobeNewswire
·
April 17, 2025
SAN DIEGO, April 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug Administration (FDA) …
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
GlobeNewswire
·
April 17, 2025
--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: …
Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23
GlobeNewswire
·
April 17, 2025
GAITHERSBURG, Md., April 17, 2025 (GLOBE NEWSWIRE) -- Bullfrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …
Cycurion Reports Full Year 2024 Financial Results
GlobeNewswire
·
April 17, 2025
MCLEAN, Va., April 17, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, reports financial results for full year ended December 31, 2024, and provides a corporate update …
Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
GlobeNewswire
·
April 17, 2025
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Intermap Announces Dates for First Quarter Earnings and AGM
GlobeNewswire
·
April 17, 2025
Company will announce first quarter 2025 financial results and host a conference call on May 15, 2025 Company will host its Annual General Meeting on June 26, 2025 DENVER, April 17, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“ …
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
GlobeNewswire
·
April 17, 2025
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics License Application submission expected in the second …
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications
GlobeNewswire
·
April 17, 2025
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …
Atana Recognized for Innovation and Technology in Ragan’s 2025 Employee Communications Awards
GlobeNewswire
·
April 17, 2025
BELLEVUE, Wash., April 17, 2025 (GLOBE NEWSWIRE) -- Seeking to redefine workplace culture and training, Atana is proud to announce that it has been named a winner in Ragan’s Employee Communications Awards. The Innovation and Technology Award for HR Tool/ …